MARKET RADAR
SENSEX     NIFTY      Refresh
Moneycontrol.com India | Notes to Account > Finance - Investments > Notes to Account from Lifeline Drugs & Pharma - BSE: 506113, NSE: N.A
YOU ARE HERE > MONEYCONTROL > MARKETS > FINANCE - INVESTMENTS > NOTES TO ACCOUNTS - Lifeline Drugs & Pharma
Lifeline Drugs & Pharma
BSE: 506113|ISIN: INE776N01010|SECTOR: Finance - Investments
SET ALERT
|
ADD TO PORTFOLIO
|
WATCHLIST
LIVE
BSE
May 24, 17:00
75.20
1.45 (1.97%)
VOLUME 1
Lifeline Drugs & Pharma is not listed on NSE
« Mar 11
Notes to Accounts Year End : Mar '12
a) Previous year figures are regrouped wherever necessary.
 
 b) There is no foreign exchange earning or expenditure.
 
 c) Contignet liability : NIL
 
 d) Loans and advances , deposits, Sundry Debtors and Creditors are
 subject to confirmation.
 
 e) In accordance with the requirement of Accounting Standard 17,
 Segmental Reporting, the company has only one Segment during the
 previous year, hence it is not required to give report on the same.
 
 f) Related Party Disclosure
 
 As per accounting standard-18, issued by Institute of Chartered
 Accountant of India, the disclosures of transactions with related
 parties and define in the Accounting Standard are given below.
 
 Related Parties
 
 a) Prominent Tours & Travels Pvt. Ltd.
 
 b) Nikunj Kankia - Director
 
 c) Pratick Garodia - Director Transaction with Related Parties : NIL
 
 g) There are no reportable amount of dues on account of principal and
 interest or any such payments during the year as required by Micro,
 Small and Medium Enterprises Development Act, 2006 in respect of Micro
 Enterprises and small enterprises as defined in the Act. This is based
 on information made available to the company by such enterprises.
 
 h) The open offer submitted by merchant banker to acquire 48000 equity
 shares by Ivory Consulatants Pvt. Ltd on 30/09/2010 is still pending.
 
 i) Additional information pursuant to the provision of para3, 4C and 4D
 of part II of the Schedule VI to the Companies Act, 1956.
 
 (a) Company is a trading company hence the clause regarding capacities,
 
 (b) Details of Quantitative trading of Shares & Securites.
 
 j) The financial statements for the year ended March 31, 2011 were
 prepared as per the applicable, pre-revised Schedule-VI to the
 Companies Act, 1956. The financial statements for the year ended March
 31,2012 have been prepared as per Schedule VI. Accordingly ,the
 previous year figures have been reclassified to confirm to current
 year''s classification.
Source : Dion Global Solutions Limited
Quick Links for lifelinedrugspharma
Explore Moneycontrol
Stocks     A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z | Others
Mutual Funds     A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z
Copyright © e-Eighteen.com Ltd. All rights reserved. Reproduction of news articles, photos, videos or any other content in whole or in part in any form or medium without express written permission of moneycontrol.com is prohibited.